documents: EPA-HQ-OPP-2008-0687-0020
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPA-HQ-OPP-2008-0687-0020 | EPA | EPA-HQ-OPP-2008-0687 | Letter from Edward Cox, MD, MPH, Director, Office of Antimicrobial Products, Office of New Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration (FDA) to Michael L. Goodis, P.E., Director, Registration Division, Office of Pesticide Programs, U.S. Environmental Protection Agency (EPA) dated April 6, 2018 | Supporting & Related Material | Letter | 2019-03-18T04:00:00Z | 2019 | 3 | 2019-03-18T21:45:10Z | 0 | 0 | 09000064839ca587 |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref